Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2008-05-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.0802203105PMID 18490657PMCID PMC2387184
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Deciphering Human Immunodeficiency Virus Type 1 Transmission and Early Envelope Diversification by Single-Genome Amplification and Sequencing

  2008cited by this paper
• Initial Events in Establishing Vaginal Entry and Infection by Human Immunodeficiency Virus Type-1

  2007cited by this paper
• Selective transmission of CCR5-utilizing HIV-1: the 'gatekeeper' problem resolved?

  2006cited by this paper
• Multiple, Linked Human Immunodeficiency Virus Type 1 Drug Resistance Mutations in Treatment-Experienced Patients Are Missed by Standard Genotype Analysis

  2005cited by this paper
• Virus Isolates during Acute and Chronic Human Immunodeficiency Virus Type 1 Infection Show Distinct Patterns of Sensitivity to Entry Inhibitors

  2005cited by this paper
• Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda.

  2005cited by this paper
• Natural Variation in Vif: Differential Impact on APOBEC3G/3F and a Potential Role in HIV-1 Diversification

  2005cited by this paper
• Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies

  2005cited by this paper
• Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection.

  2005cited by this paper
• Human Immunodeficiency Virus Type 1 (HIV-1) Diversity at Time of Infection Is Not Restricted to Certain Risk Groups or Specific HIV-1 Subtypes

  2004cited by this paper
• Envelope-Constrained Neutralization-Sensitive HIV-1 After Heterosexual Transmission

  2004cited by this paper
• Multiple V1/V2 env Variants Are Frequently Present during Primary Infection with Human Immunodeficiency Virus Type 1

  2004cited by this paper
• Incidence of HIV-1 dual infection and its association with increased viral load set point in a cohort of HIV-1 subtype C-infected female sex workers.

  2004cited by this paper
• Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection

  2003cited by this paper
• Inhibiting sexual transmission of HIV-1 infection

  2003cited by this paper
• A Novel Antiviral Intervention Results in More Accurate Assessment of Human Immunodeficiency Virus Type 1 Replication Dynamics and T-Cell Decay In Vivo

  2003cited by this paper
• Antibody neutralization and escape by HIV-1

  2003cited by this paper
• Virus Population Homogenization following Acute Human Immunodeficiency Virus Type 1 Infection

  2002cited by this paper
• Modeling plasma virus concentration during primary HIV infection.

  2000cited by this paper
• Gender differences in HIV-1 diversity at time of infection

  2000cited by this paper
• HIV Quasispecies and Resampling

  1996cited by this paper
• Diversity in virus populations from genital secretions and peripheral blood from women recently infected with human immunodeficiency virus type 1

  1995cited by this paper
• Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase

  1995cited by this paper
• Viral dynamics in human immunodeficiency virus type 1 infection

  1995cited by this paper
• Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

  1995cited by this paper
• Genotypic and phenotypic characterization of HIV-1 patients with primary infection.

  1993cited by this paper
• Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants.

  1992cited by this paper
• HIV-1 genomic RNA diversification following sexual and parenteral virus transmission.

  1992cited by this paper
• Pairwise comparisons of mitochondrial DNA sequences in stable and exponentially growing populations.

  1991cited by this paper
• DNA recombination during PCR.

  1990cited by this paper
• Edinburgh Research Explorer Analysis of sequence diversity in hypervariable regions of the external glycoprotein of human immunodeficiency virus type 1

  year unknowncited by this paper

• Multiple Infections, Recombination, and Hypermutation During a 12-Month Prospective Study of Five HIV-1 Infected Individuals

  2026cites this paper
• Cytotoxic CD4 T Cells: Dual Agents in HIV-1 Pathogenesis and Persistence

  2026cites this paper
• Dissecting the steps in early simian immunodeficiency virus dissemination following mucosal and intravenous infection of rhesus macaques

  2026cites this paper
• Autologous neutralizing antibodies and polyfunctional T cells contribute to long-term HIV-1 post-intervention control.

  2026cites this paper
• Functional Convergence of Genetically Diverse B-Cell Receptors in Simian-HIV Infected Rhesus Macaques

  2026cites this paper
• HIV-1 Vpr is targeted for degradation by autophagy.

  2026cites this paper
• NanoHIVSeq: A Long-Read Bioinformatics Pipeline for High-Throughput Processing of HIV Env Sequences

  2026cites this paper
• In vivo HSC gene therapy enables sustained eCD4-Ig expression for SIV prevention

  2026cites this paper
• Parallel evolution of full-length genomes in a long-term evolution experiment with phage φX174

  2025cites this paper
• Consistent Induction of Broadly Neutralizing HIV Antibodies by a Novel Two-Step Mechanism Informs Immunogen Design

  2025cites this paper
• Single genome amplification and molecular cloning of HIV-1 populations in acute HIV-1 infection: implications for studies on HIV-1 diversity and evolutionary rate

  2025cites this paper
• Acute HIV-1 Infection: Paradigm and Singularity

  2025influential citation
• Bird's Eye View on Mycobacterium tuberculosis-HIV Coinfection: Understanding the Molecular Synergism, Challenges, and New Approaches to Therapeutics.

  2025cites this paper
• Tradeoffs between proliferation and transmission in virus evolution– insights from evolutionary and functional analyses of SARS-CoV-2

  2025cites this paper
• HUMAN IMMUNODEFICIENCY VIRUS: ELUSIVE PERSPECTIVES AND NOVEL VACCINATION APPROACHES

  2025cites this paper
• Near extinction of the HBV quasispecies driven by the hard selective sweep in chronic hepatitis B

  2025influential citation
• Unique molecular signatures in rebound viruses from antiretroviral drug and CRISPR-treated HIV-1-infected humanized mice

  2025cites this paper
• Inhibitory potential of autologous neutralizing antibodies sets quantitative limits on the rebound-competent HIV-1 reservoir

  2025cites this paper
• Env-antibody coevolution identifies B cell priming as the principal bottleneck to HIV-1 V2 apex broadly neutralizing antibody development

  2025cites this paper
• Patterns of inflammation and immune activation by coreceptor use in people living with HIV-1

  2025cites this paper
• Vaccine sieve analysis on deep sequencing data using competing risks Cox regression with failure type subject to misclassification

  2025cites this paper
• Differences in neutralization susceptibility between clade C HIV viruses from breastmilk versus contemporaneous circulating viruses from sexually acquired infections

  2025cites this paper
• Evolutionary Sequence and Structural Basis for the Epistatic Origins of Drug Resistance in HIV

  2025cites this paper
• VRC01 Selects Rare HIV Escape Mutations After Acquisition in Antibody-Mediated Prevention Trials

  2025cites this paper
• The Future of Gene Expression Studies in HIV Research.

  2025cites this paper
• Virologic effects of broadly neutralizing antibodies VRC01LS and VRC07-523LS on chronic HIV-1 infection

  2025cites this paper
• SIV proviruses seeded later in infection are harbored in short-lived CD4+ T cells

  2025cites this paper
• BonoboFlow: viral genome assembly and haplotype reconstruction from nanopore reads

  2025cites this paper
• Dendritic cell-based vaccines, a promising prospect for ending AIDS and eradication of HIV worldwide: A narrative review on the latest updates.

  2025cites this paper
• Validation of High-throughput Oxford Nanopore Technology for HIV-1 Transmitted/Founder Virus Identification.

  2025cites this paper
• Unique genetic signatures in HIV-1 subtype A1 and A1D recombinant envelope glycoprotein distinguish contemporary transmitted/founder viruses from historical strains in East Africa

  2025cites this paper
• Incompletely closed HIV-1CH040 envelope glycoproteins resist broadly neutralizing antibodies while mediating efficient HIV-1 entry

  2025cites this paper
• Viral Simulation Reveals Overestimation Bias in Within-Host Phylodynamic Migration Rate Estimates Under Selection

  2025influential citation
• Development and validation of a multiplex assay system for simultaneous detection of HIV-1, HBV, and human STRs for forensic application on CE system

  2025cites this paper
• Metagenomics identification of genetically distinct tick virome in India unveils signs of purifying selection, and APOBEC and ADAR editing

  2025cites this paper
• Transmitted/founder (T/F) HIV-1 derived from sexual contact exhibits greater transmission fitness in human cervical tissue than T/F HIV-1 from blood-to-blood contact: Unique glycan profiles on T/F envelopes associated with transmission phenotypes

  2025cites this paper
• A broad antibody with enhanced HIV-1 neutralization via bispecific antibody-mediated prepositioning

  2025cites this paper
• Temporal dynamics of viral fitness and the adaptive immune response in HCV infection

  2025cites this paper
• Genetic signatures in the highly virulent subtype B human immunodeficiency virus-1 conferring resistance to broadly neutralizing antibodies

  2025cites this paper
• The conformational epitope of a gp41-specific mucosal protective IgA binds to the HIV-1 envelope and neutralizes infection

  2025cites this paper
• Distinct neutralization sensitivity between adult and infant transmitted/founder HIV-1 subtype C viruses to broadly neutralizing monoclonal antibodies

  2025cites this paper
• Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials

  2025cites this paper
• Exceptionally broad HIV-1 neutralization via bispecific antibody–mediated prepositioning

  2025cites this paper
• Bayesian estimation of HIV acquisition dates for prevention trials

  2025cites this paper
• Long-Read Deep Sequencing Reveals High Rates of Multilineage Transmission and Rapid Viral Population Changes in Acute HIV Infection

  2025cites this paper
• Endocervix exhibits greater susceptibility to HIV-1 infection compared to ectocervix following ex vivo exposure to Transmitted/Founder HIV-1 variants

  2025cites this paper
• A national cross-sectional analysis of surveillance drug resistance mutations among recently diagnosed antiretroviral naïve Brazilian people with HIV

  2025cites this paper
• Computer‐Aided Algorithmic Approaches to Drug Development for Multi‐Mutant HIV‐1 Reverse Transcriptase

  2025cites this paper
• Phylogenetics and molecular evolution to understand and curb the HIV pandemic

  2025cites this paper
• A novel glia-immune humanized mouse model for investigating neuroimmune mechanisms in CNS HIV infection and diverse neurological disorders

  2025cites this paper
• Resistance mutations that distinguish HIV-1 envelopes with discordant VRC01 phenotypes from multi-lineage infections in the HVTN703/HPTN081 trial: implications for cross-resistance

  2025cites this paper
• HIV-1 Rebound Virus Consists of a Small Number of Lineages That Entered the Reservoir Close to ART Initiation

  2025cites this paper
• Contribution of intact viral genomes persisting in blood and tissues during ART to plasma viral rebound in SHIV-infected rhesus macaques

  2025cites this paper
• Heterologous Immunization with Improved HIV-1 Subtype C Vaccines Elicit Autologous Tier 2 Neutralizing Antibodies with Rapid Viral Replication Control After SHIV Challenge

  2025cites this paper
• Transient glycan shield reduction induces CD4-binding site broadly neutralizing antibodies in SHIV-infected macaques

  2025cites this paper
• Fostemsavir analog BMS-818251 has enhanced viral neutralization potency and similar escape mutation profile

  2025cites this paper
• Variability in HIV-1 transmitted/founder virus susceptibility to combined APOBEC3F and APOBEC3G host restriction

  2024cites this paper
• Antiviral factors and their counteraction by HIV-1: many uncovered and more to be discovered

  2024cites this paper
• Host ZCCHC3 blocks HIV-1 infection and production through a dual mechanism

  2024cites this paper
• It's all in the gut: the central role of the gut and microbiome in preventing disease progression in simian immunodeficiency viruses infected African nonhuman primates

  2024cites this paper
• Antibodies targeting the fusion peptide on the HIV envelope provide protection to rhesus macaques against mucosal SHIV challenge

  2024cites this paper
• The chemokine receptor CCR5: multi-faceted hook for HIV-1

  2024cites this paper
• HIV-1 Vif global diversity and possible APOBEC-mediated response since 1980

  2024cites this paper
• Mechanisms of sterilizing immunity provided by an HIV-1 neutralizing antibody against mucosal infection

  2024cites this paper
• Virulence and Replicative Fitness of HIV-1 Transmitted/Founder (T/F) Viruses Harbouring Drug Resistance-Associated Mutation

  2024cites this paper
• Functional variability of Nef in antagonizing SERINC5 during acute to chronic HIV-1 infection

  2024cites this paper
• Rapid systemic spread and minimal immune responses following SIVsab intrarectal transmission in African green monkeys

  2024cites this paper
• Genetic Characteristics of the Env Regions in HIV-1-Infected Subjects in Baoding City, Hebei Province, China.

  2024cites this paper
• High HIV diversity, recombination, and superinfection revealed in a large outbreak among persons who inject drugs in Kentucky and Ohio, USA.

  2024cites this paper
• Reconciling founder variant multiplicity of HIV-1 infection with the rate of CD4+ decline

  2024cites this paper
• Phenotypic Characterization of Subtype A and Recombinant AC Transmitted/Founder Viruses from a Rwandan HIV-1 Heterosexual Transmission Cohort

  2024influential citation
• Transmission of highly virulent CXCR4 tropic HIV-1 through the mucosal route in an individual with a wild-type CCR5 genotype

  2024cites this paper
• HIV-1 diversity in viral reservoirs obtained from circulating T-cell subsets during early ART and beyond

  2024cites this paper
• Host cell glycosylation selects for infection with CCR5- versus CXCR4-tropic HIV-1

  2024influential citation
• Help or Hinder: Protein Host Factors That Impact HIV-1 Replication

  2024cites this paper
• Conformational flexibility of HIV-1 envelope glycoproteins modulates transmitted/founder sensitivity to broadly neutralizing antibodies

  2024cites this paper
• Experimental genital tract infection demonstrates Neisseria gonorrhoeae MtrCDE efflux pump is not required for in vivo human infection and identifies gonococcal colonization bottleneck

  2024cites this paper
• Mosaic HIV-1 vaccine and SHIV challenge strain V2 loop sequence identity and protection in primates

  2024cites this paper
• Rare twin cysteine residues in the HIV-1 envelope variable region 1 link to neutralization escape and breadth development

  2024cites this paper
• Evolution and diversity of the hepatitis B virus genome: Clinical implications.

  2024cites this paper
• The Performance of the Current Algorithm of HIV Diagnosis

  2024cites this paper
• Modeling of HIV‐1 prophylactic efficacy and toxicity with islatravir shows non‐superiority for oral dosing, but promise as a subcutaneous implant

  2024cites this paper
• Safety and antiviral effect of a triple combination of HIV-1 broadly neutralizing antibodies: a phase 1/2a trial

  2024cites this paper
• The interferon-regulated host factor hnRNPA0 modulates HIV-1 production by interference with LTR activity, mRNA trafficking, and programmed ribosomal frameshifting

  2024cites this paper
• Higher HIV-1 evolutionary rate is associated with cytotoxic T lymphocyte escape mutations in infants

  2024influential citation
• SAMD9L acts as an antiviral factor against HIV-1 and primate lentiviruses by restricting viral and cellular translation

  2024cites this paper
• Comprehensive insights into herbal P-glycoprotein inhibitors and nanoformulations for improving anti-retroviral therapy efficacy

  2024cites this paper
• Phylobook: a tool for display, clade annotation and extraction of sequences from molecular phylogenies.

  2024cites this paper
• Premature Activation of the HIV-1 Protease Is Influenced by Polymorphisms in the Hinge Region

  2024cites this paper
• A long-term stable cold-chain-friendly HIV mRNA vaccine encoding multi-epitope viral protease cleavage site immunogens inducing immunogen-specific protective T cell immunity

  2024cites this paper
• A Plausible Framework Reveals Potential Similarities in the Regulation of Immunity against Some Cancers and Some Infectious Agents: Implications for Prevention and Treatment

  2024cites this paper
• Rapid Biphasic Decay of Intact and Defective HIV DNA Reservoir During Acute Treated HIV Disease

  2024cites this paper
• Sequence Analysis of Inducible, Replication-Competent Virus Reveals No Evidence of HIV-1 Evolution During Suppressive Antiviral Therapy, Indicating a Lack of Ongoing Viral Replication

  2024cites this paper
• Autologous neutralizing antibody responses after antiretroviral therapy in acute and early HIV-1

  2024cites this paper
• Genetic signatures in the highly virulent subtype B HIV-1 conferring immune escape to V1/V2 and V3 broadly neutralizing antibodies

  2024cites this paper
• Unraveling clinical outcomes of long-term cART treatment in HIV-1 patients with or without the Brazilian GWGR motif in the V3 loop

  2024cites this paper
• Potent and broad HIV-1 neutralization in fusion peptide-primed SHIV-infected macaques.

  2024cites this paper
• Rapid biphasic decay of intact and defective HIV DNA reservoir during acute treated HIV disease

  2024cites this paper
• Using viral sequence diversity to estimate time of HIV infection in infants

  2023cites this paper
• Molecular evolution of 2022 multi-country outbreak-causing monkeypox virus Clade IIb

  2023cites this paper